target
  PyMOL3.0          3D                             0

 15 16  0  0  0  0  0  0  0  0999 V2000
   10.0015   -0.5220   25.0692 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2149   -0.5030   24.2811 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.5358   -1.6922   23.5442 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7563   -1.6469   22.6522 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7317   -0.5197   22.9417 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9839    0.8273   23.1680 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5386    2.0410   22.7098 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8517    3.2377   22.9151 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6063    3.1997   23.5805 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0506    2.0030   24.0357 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7467    0.7934   23.8256 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6781    4.7128   23.8810 S   0  0  0  0  0  0  0  0  0  0  0  0
   10.2320    4.6831   25.2750 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.3996    4.6877   23.1563 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.6325    6.0783   23.5055 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  4  0  0  0  0
  6 11  4  0  0  0  0
  7  8  4  0  0  0  0
  8  9  4  0  0  0  0
  9 12  1  0  0  0  0
  9 10  4  0  0  0  0
 10 11  4  0  0  0  0
  2 11  1  0  0  0  0
 12 13  2  0  0  0  0
 12 14  2  0  0  0  0
 12 15  1  0  0  0  0
M  END
>  <pdb_header>
HEADER    HYDROLASE/HYDROLASE INHIBITOR           03-MAR-20   XXXX              
TITLE     PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF COVID-19 MAIN
TITLE    2 PROTEASE IN COMPLEX WITH Z1367324110                                 
KEYWDS    SGC - DIAMOND I04-1 FRAGMENT SCREENING, PANDDA, XCHEMEXPLORER,        
KEYWDS   2 HYDROLASE-HYDROLASE INHIBITOR COMPLEX                                
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    D.FEARON,A.J.POWELL,A.DOUANGAMATH,C.D.OWEN,C.WILD,T.KROJER,P.LUKACIK, 
AUTHOR   2 C.M.STRAIN-DAMERELL,M.A.WALSH,F.VON DELFT                            
JRNL        AUTH   A.DOUANGAMATH,D.FEARON,P.GEHRTZ,T.KROJER,P.LUKACIK,C.D.OWEN, 
JRNL        AUTH 2 E.RESNICK,C.STRAIN-DAMERELL,A.AIMON,P.ABRANYI-BALOGH,        
JRNL        AUTH 3 J.BRANDAO-NETO,A.CARBERY,G.DAVISON,A.DIAS,T.D.DOWNES,        
JRNL        AUTH 4 L.DUNNETT,M.FAIRHEAD,J.D.FIRTH,S.P.JONES,A.KEELEY,           
JRNL        AUTH 5 G.M.KESERU,H.F.KLEIN,M.P.MARTIN,M.E.M.NOBLE,P.O'BRIEN,       
JRNL        AUTH 6 A.POWELL,R.N.REDDI,R.SKYNER,M.SNEE,M.J.WARING,C.WILD,        
JRNL        AUTH 7 N.LONDON,F.VON DELFT,M.A.WALSH                               
JRNL        TITL   CRYSTALLOGRAPHIC AND ELECTROPHILIC FRAGMENT SCREENING OF THE 
JRNL        TITL 2 SARS-COV-2 MAIN PROTEASE.                                    
JRNL        REF    NAT COMMUN                    V.  11  5047 2020              
JRNL        REFN                   ESSN 2041-1723                               
JRNL        PMID   33028810                                                     
JRNL        DOI    10.1038/S41467-020-18709-W                                   
SEQRES   1 A  306  SER GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL          
SEQRES   2 A  306  GLU GLY CYS MET VAL GLN VAL THR CYS GLY THR THR THR          
SEQRES   3 A  306  LEU ASN GLY LEU TRP LEU ASP ASP VAL VAL TYR CYS PRO          
SEQRES   4 A  306  ARG HIS VAL ILE CYS THR SER GLU ASP MET LEU ASN PRO          
SEQRES   5 A  306  ASN TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS ASN          
SEQRES   6 A  306  PHE LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE          
SEQRES   7 A  306  GLY HIS SER MET GLN ASN CYS VAL LEU LYS LEU LYS VAL          
SEQRES   8 A  306  ASP THR ALA ASN PRO LYS THR PRO LYS TYR LYS PHE VAL          
SEQRES   9 A  306  ARG ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS          
SEQRES  10 A  306  TYR ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET          
SEQRES  11 A  306  ARG PRO ASN PHE THR ILE LYS GLY SER PHE LEU ASN GLY          
SEQRES  12 A  306  SER CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS          
SEQRES  13 A  306  VAL SER PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR          
SEQRES  14 A  306  GLY VAL HIS ALA GLY THR ASP LEU GLU GLY ASN PHE TYR          
SEQRES  15 A  306  GLY PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY          
SEQRES  16 A  306  THR ASP THR THR ILE THR VAL ASN VAL LEU ALA TRP LEU          
SEQRES  17 A  306  TYR ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN          
SEQRES  18 A  306  ARG PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA          
SEQRES  19 A  306  MET LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL          
SEQRES  20 A  306  ASP ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA          
SEQRES  21 A  306  VAL LEU ASP MET CYS ALA SER LEU LYS GLU LEU LEU GLN          
SEQRES  22 A  306  ASN GLY MET ASN GLY ARG THR ILE LEU GLY SER ALA LEU          
SEQRES  23 A  306  LEU GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN          
SEQRES  24 A  306  CYS SER GLY VAL THR PHE GLN                                  
HETNAM     RZJ 1-METHYL-3,4-DIHYDRO-2~{H}-QUINOLINE-7-SULFONAMIDE               
HETNAM     DMS DIMETHYL SULFOXIDE                                               
FORMUL   2  RZJ    C10 H14 N2 O2 S                                              
FORMUL   3  DMS    4(C2 H6 O S)                                                 
FORMUL   7  HOH   *334(H2 O)                                                    
HELIX    1 AA1 SER A   10  GLY A   15  1                                   6    
HELIX    2 AA2 HIS A   41  CYS A   44  5                                   4    
HELIX    3 AA3 ASN A   53  ILE A   59  1                                   7    
HELIX    4 AA4 ARG A   60  LYS A   61  5                                   2    
HELIX    5 AA5 SER A   62  HIS A   64  5                                   3    
HELIX    6 AA6 ILE A  200  ASN A  214  1                                  15    
HELIX    7 AA7 THR A  226  TYR A  237  1                                  12    
HELIX    8 AA8 THR A  243  LEU A  250  1                                   8    
HELIX    9 AA9 LEU A  250  GLY A  258  1                                   9    
HELIX   10 AB1 ALA A  260  GLY A  275  1                                  16    
HELIX   11 AB2 THR A  292  GLY A  302  1                                  11    
SHEET    1 AA1 7 VAL A  73  LEU A  75  0                                        
SHEET    2 AA1 7 PHE A  66  ALA A  70 -1  N  VAL A  68   O  LEU A  75           
SHEET    3 AA1 7 MET A  17  CYS A  22 -1  N  GLN A  19   O  GLN A  69           
SHEET    4 AA1 7 THR A  25  LEU A  32 -1  O  LEU A  27   N  VAL A  20           
SHEET    5 AA1 7 VAL A  35  PRO A  39 -1  O  TYR A  37   N  LEU A  30           
SHEET    6 AA1 7 VAL A  86  VAL A  91 -1  O  LEU A  89   N  VAL A  36           
SHEET    7 AA1 7 VAL A  77  GLN A  83 -1  N  SER A  81   O  LYS A  88           
SHEET    1 AA2 5 LYS A 100  PHE A 103  0                                        
SHEET    2 AA2 5 CYS A 156  GLU A 166  1  O  PHE A 159   N  LYS A 102           
SHEET    3 AA2 5 VAL A 148  ASP A 153 -1  N  ASN A 151   O  SER A 158           
SHEET    4 AA2 5 THR A 111  TYR A 118 -1  N  SER A 113   O  PHE A 150           
SHEET    5 AA2 5 SER A 121  ALA A 129 -1  O  CYS A 128   N  PHE A 112           
SHEET    1 AA3 3 LYS A 100  PHE A 103  0                                        
SHEET    2 AA3 3 CYS A 156  GLU A 166  1  O  PHE A 159   N  LYS A 102           
SHEET    3 AA3 3 HIS A 172  THR A 175 -1  O  ALA A 173   N  MET A 165           
SITE     1 AC1 10 HIS A  41  MET A  49  GLU A 166  PRO A 168                    
SITE     2 AC1 10 ASP A 187  ARG A 188  GLN A 189  PRO A 252                    
SITE     3 AC1 10 HOH A1159  HOH A1259                                          
SITE     1 AC2  8 GLN A  74  ARG A  76  ARG A 222  PHE A 223                    
SITE     2 AC2  8 THR A 224  ASP A 263  HOH A1158  HOH A1283                    
SITE     1 AC3  6 MET A   6  PHE A   8  SER A 123  GLN A 127                    
SITE     2 AC3  6 ARG A 298  HOH A1235                                          
SITE     1 AC4  2 GLY A  15  MET A  17                                          
SITE     1 AC5  5 PHE A 140  LEU A 141  HIS A 163  MET A 165                    
SITE     2 AC5  5 GLU A 166                                                     
CRYST1  113.780   53.490   44.450  90.00 101.70  90.00 C 1 2 1       4          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.008789  0.000000  0.001820        0.00000                         
SCALE2      0.000000  0.018695  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.022975        0.00000                         


$$$$
